Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Abatacept for the Treatment of Giant Cell Arteritis [Phase 3]
Ongoing Phase 3 clinical trial evaluating abatacept for giant cell arteritis; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]
A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: One-Time DNA Study for Vasculitis
A University of Pennsylvania-led trial is recruiting for a one-time DNA study of various vasculitides, including eosinophilic granulomatosis…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: VCRC Tissue Repository
The University of Pennsylvania–sponsored VCRC Tissue Repository trial is currently recruiting. It covers multiple forms of vasculitis.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
A clinical trial is evaluating upadacitinib for Giant Cell Arteritis with active large-vessel involvement (NCT07354906), sponsored by Groupe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-01-14FDA Approved: AVTOZMA — Supplemental Application (CELLTRION USA, Inc.)
FDA approves a supplemental application for AVTOZMA (tocilizumab) filed by Celltrion USA, Inc.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) [Phase 2]
Phase 2 clinical trial DERAIL-LVV is evaluating the combination of dapagliflozin with endothelin receptor antagonism for large vessel vascul…
-
CLINICAL_TRIALS withdrawal · 2026-01-12Clinical Trial Update: TocilizuMab discontinuAtion in GIant Cell Arteritis [Phase 3]
A Phase 3 trial of tocilizumab for giant cell arteritis has been discontinued.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)
This clinical trial update examines how the spatial resolution of contrast-enhanced 3D T1-weighted MRI sequences affects the diagnosis of gi…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment [Phase 4]
Phase 4 clinical trial evaluating hydrocortisone versus placebo in patients with symptoms of adrenal insufficiency after stopping glucocorti…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Giant Cell Arteritis - Ways to Precision Medicine
A recruiting clinical trial at Würzburg University Hospital explores precision medicine approaches for Giant Cell Arteritis and Polymyalgia …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)
A clinical trial update describing RituxiMAP GCA, a study to map B-cell biology in Giant Cell Arteritis to identify a new therapeutic approa…
-
FDA approval · 2025-12-10FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc.
-
FDA label_change · 2025-12-10FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Actemra (tocilizumab) submitted by Genentech, Inc., related to changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
A clinical trial investigating orbital vascular inflammation in Giant Cell Arteritis and ischemic optic neuropathy (including NAION). The st…
-
EMA approval · 2025-10-02EMA Authorised: Tyenne (tocilizumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Tyenne (tocilizumab) by Fresenius Kabi Deutschland GmbH for multiple indications, including rheumatoid arthritis, juvenile id…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
This clinical trial update describes an ongoing study aimed at improving diagnostics and monitoring for Polymyalgia Rheumatica, with Giant C…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
Sponsored by the University of Pennsylvania, the VEGA trial evaluates vascular MRI approaches in Giant Cell Arteritis. The study is currentl…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound [NA]
A clinical trial evaluating optic nerve sheath evaluation in giant cell arteritis using ultrasound is currently recruiting at Hôpital NOVO.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
A pilot clinical study (THROPIQ) is evaluating whether thrombomodulin can help rule out giant cell arteritis in patients with polymyalgia rh…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
This clinical trial update describes ongoing research in safety and efficacy assessment for rheumatologic diseases and related conditions, w…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis
The clinical trial assesses FDG PET/CT as a first-line diagnostic tool for Giant Cell Arteritis, with the study sponsored by Jewish General …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: The Applanation Tonometry in GCA Pilot
This clinical trial update describes a pilot study evaluating applanation tonometry in Giant Cell Arteritis, currently active but not recrui…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
A clinical trial is currently recruiting to evaluate the use of optic nerve sheath ultrasound in patients with giant cell arteritis and rela…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients [NA]
This clinical trial update describes a study in Giant Cell Arteritis evaluating halo sign vanishing time after steroid treatment; the trial …